Monday 30 January 2023, at The Ballroom, Aryaduta Menteng, Jakarta, PT Indofarma Tbk has held an Extraordinary General Meeting of Shareholders (EGMS).
This EGMS decided to Confirm the Enforcement of the Regulation of the Minister of State-Owned Enterprises of the Republic of Indonesia Number: PER-5/MBU/09/2022 concerning Implementation of Risk Management in State-Owned Enterprises and its amendments.
The EGMS also decided on a change in the composition of the Company’s Management, namely the respectful dismissal of Mr. Arief Pramuhanto as the President Director of PT Indofarma Tbk with thanks for his contribution of energy and thoughts while in that position, as well as the appointment of Mr. Agus Heru Darjono as the President Director of PT Indofarma Tbk.
The following is the composition of the Board of Commissioners and Directors based on the EGMS, namely:
board of Commissioners
Main Commissioner : Laksono Trisnantoro
Commissioner : Didi Agus Mintadi
Independent Commissioner : Teddy Wibisana
Independent Commissioner : Achmad Ghufron Siradj
Main Director : Agus Heru Darjono
Director of Finance, Risk Management and Human Resources: Ariesta Krisnawan
Director of Production and Supply Chain : Jejen Nugraha Director of Sales and Marketing : Kamelia Faisal
46439total visits,7visits today